NVO

Novo Nordisk A/S (NVO)

Last Price$86.30.8%
Market Cap$384.7B
42.9%
Industry median - (125.1%) 5Y Historical average - 36.7%
35.9%
Industry median - (131.8%) 5Y Historical average - 30.9%
81.3%
Industry median - (52.2%) 5Y Historical average - 74.5%
50.8%
Industry median - (51.2%) 5Y Historical average - 55.2%

NVO Capital Allocation Rating

Crunching data... Almost there!

NVO Capital Allocation metrics

Crunching data... Almost there!

Competing with NVO Capital Allocation

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!

FAQ

What is the Novo Nordisk A/S (NVO) ROIC (Return on Invested Capital)?

The Novo Nordisk A/S (NVO) ROIC is 42.9%, compared to the industry median of ((125.1%)) and the 5-year historical average of 36.7%.

What is the Novo Nordisk A/S (NVO) ROIC minus WACC (Weighted Average Cost of Capital)?

The Novo Nordisk A/S (NVO) ROIC minus WACC is 35.9%, compared to the industry median of ((131.8%)) and the 5-year historical average of 30.9%.

What is the Novo Nordisk A/S (NVO) ROE (Return on Equity)?

The Novo Nordisk A/S (NVO) ROE is 81.3%, compared to the industry median of ((52.2%)) and the 5-year historical average of 74.5%.

What is the Novo Nordisk A/S (NVO) ROCE (Return on Capital Employed)?

The Novo Nordisk A/S (NVO) ROCE is 50.8%, compared to the industry median of ((51.2%)) and the 5-year historical average of 55.2%.